The 10% revenue growth and margin expansion are positive, but the company remains unprofitable and cash-burning, relying on a related-party loan. The SpinDetect commercial launch in Q1 2027 is the key catalyst; monitor for beta testing results and any additional financing needs before that.
Price Chart
Executive Summary
Lifeloc Technologies reported Q2 2026 revenue of $2.445M, up 10% YoY from $2.219M, and a net loss of $(0.05)/share, narrowing from a $(0.14)/share loss in Q2 2025. Gross margin improved to 45% from 42%, driven by pricing and product mix, though R&D spending remained high at $560K for SpinDetect development. The company is progressing toward a limited commercial launch of its SpinDetect drug analyzer in Q1 2027, but continues to operate at a loss and relies on a $500K related-party loan for liquidity.
Key Financial Metrics
Key Facts
- Q2 2026 revenue of $2.445M, up 10% YoY from $2.219M.
- Net loss narrowed to $(134K) or $(0.05)/diluted share from $(394K) or $(0.14)/share in Q2 2025.
- Gross margin improved to 45% from 42% YoY.
- R&D spending remained high at $560K, primarily for SpinDetect analyzer development.
- SpinDetect beta testing to begin under signed agreement, targeting limited commercial launch in Q1 2027.
- Closed $500K related-party loan from Chairman/CFO during the quarter; loan is secured by all assets.
- Cash and cash equivalents increased to $908K from $746K at year-end 2025, aided by the $500K loan.
- Operating cash flow was negative $(263K) for the first six months of 2026.
- Accumulated deficit grew to $(2.118M) from $(1.831M) at year-end 2025.
Financial Impact
Revenue grew 10% YoY to $2.445M, net loss improved 66% YoY to $(134K). Gross margin expanded 300bps to 45%.
Risk Factors
- Continued operating losses and negative cash flow from operations.
- Dependence on related-party loan for liquidity; no guarantee of future financing.
- SpinDetect commercialization may be delayed or fail to generate meaningful revenue.
- Small market cap and OTC listing limit liquidity and institutional interest.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001079973-26-001110 |
| Document: lctc_8k.htm | 0001079973-26-001110 |
| Document: 0001079973-26-001110-index-headers.html | 0001079973-26-001110 |
| Document: 0001079973-26-001110-index.html | 0001079973-26-001110 |
| Document: 0001079973-26-001110.txt | 0001079973-26-001110 |
| 8-K Data (Synthetic) | 0001079973-26-001110 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 8-K | $4.00 $4.25 | ▲ +6.25% | ▲ +8.24% | $3.50 (−12.50%) |
Jun 5, 2026 20w ago | 8-K | $2.20 $3.39 | ▲ +54.09% | ▲ +52.68% | $3.50 (+59.09%) |
May 19, 2026 22w ago | 8-K | $2.18 $2.70 | ▲ +23.85% | ▲ +22.87% | $3.50 (+60.55%) |
May 8, 2026 24w ago | 8-K | $2.05 $2.16 | ▲ +5.37% | ▲ +5.67% | $3.50 (+70.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers